Maple Valley, WA, United States of America

Gabriel M Galvin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Manlius, NY (US) (2007)
  • Maple Valley, WA (US) (2007 - 2008)

Company Filing History:


Years Active: 2007-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Gabriel M Galvin

Introduction

Gabriel M Galvin is a notable inventor based in Maple Valley, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dipeptidyl peptidase IV inhibitors. With a total of three patents to his name, his work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Gabriel's latest patents include a process for preparing a dipeptidyl peptidase IV inhibitor and the intermediates employed therein. This innovative process involves treating a specific structure with TFAA in isopropyl acetate to protect the tertiary hydroxyl group as a trifluoroacetate group. This results in the formation of a novel intermediate, which is then converted to an acid chloride compound using Vilsmeier reagent or other chloro reagents. The subsequent coupling with another compound in a heterogeneous mixture of ethyl acetate and aqueous bicarbonate leads to the creation of a new compound. The N,O-bis(trifluoroacetyl) groups of this compound are then deprotected to yield a free base compound.

Career Highlights

Gabriel M Galvin is currently employed at Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through the development of new therapeutic agents.

Collaborations

Throughout his career, Gabriel has collaborated with esteemed colleagues such as Padam N Sharma and Edward J Gublo. These collaborations have likely contributed to the success of his innovative projects and patents.

Conclusion

Gabriel M Galvin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work in developing dipeptidyl peptidase IV inhibitors showcases the potential for innovation in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…